Effects of Spironolactone on Serum Markers of Fibrosis in People at High Risk of Developing Heart Failure: Rationale, Design and Baseline Characteristics of a Proof‐Of‐Concept, Randomised, Precision‐Medicine, Prevention Trial. The Heart Omics in Aging (Homage) Trial

AuthID
P-00V-8NH
20
Author(s)
Pellicori, P
·
Ahmed, FZ
·
Verdonschot, J
·
Collier, T
·
Cuthbert, JJ
·
Petutschnigg, J
·
Mujaj, B
·
Girerd, N
·
González, A
·
Clark, AL
·
Cosmi, F
·
Staessen, JA
·
Heymans, S
·
Latini, R
·
Rossignol, P
·
Zannad, F
·
Cleland, JG
Tipo de Documento
Article
Year published
2020
Publicado
in European Journal of Heart Failure, ISSN: 1388-9842
Volume: 22, Número: 9, Páginas: 1711-1723
Indexing
Publication Identifiers
Source Identifiers
ISSN: 1388-9842
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.